References
- Brattström L R., Hardebo J E., Hultberg B L. Moderate homocysteinemia–a possible risk factor for arteriosclerotic cerebrovascular disease. Stroke 1984; 15: 1012–6
- Boers G HJ, Smals A GH, Trijbels F JM, Fowler B, Bakkeren J AJM, Schoonderwaldt H C., Kleijer W J., Kloppenborg P WC. Heterozygosity for homocysti-nuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 1985; 313: 709–15
- Araki A, Sako Y, Fukushima Y, Matsumoto M, Asada T, Kita T. Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects. Atherosclerosis 1989; 79: 139–46
- Malinow M R., Kang S S., Taylor L M., Wong P WK, Coull B, Inahara T, Mukerjee D, Sexton G, Upson B. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation 1989; 79: 1180–8
- Brattström L, Israelsson B, Norrving B, Bergqvist D, Thöme J, Hultberg B, Hamfelt A. Impaired homocyteine metabolism in early-onset cerebral and peripheral occlusive arterial disease–Effects of pyridoxine and folic acid treatment. Atherosclerosis 1990; 81: 51–60
- Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomo-cyst(e)inemia: an indepedent risk factor for vascular disease. N Engl J Med 1991; 324: 1149–55
- Taylor L M., De Frang R D., Harris E J., Porter J M. The association of elevated plasma homocysteine with progression of symptomatic peripheral arterial disease. J Vase Surg 1991; 13: 128–36
- Wilcken D EL, Wilcken B. The pathogenesis of coronary artery disease: a possible role of methionine metabolism. J Clin Invest 1976; 57: 1079–82
- Murphy-Chutorian D R., Wexman M P., Grieco A J., Heininger J A., Glassman E, Gaull G E., Ng S KG, Feit F, Wexman K, Fox A C. Methionine intolerance: a possible risk factor for coronary disease. J Am Coll Cardiol 1985; 6: 725–30
- Kang S, Wong P WK, Cook H Y., Norusis M, Messer J V. Protein-bound homocysteine–a possible risk factor for coronary artery disease. J Clin Invest 1986; 77: 1482–6
- Israelsson B, Brattström L, Hultberg B. Homocysteine and myocardial infarction. Athersclerosis 1988; 71: 227–34
- Malinow M R., Sexton G, Averbuch M, Grossman M, Wilson D, Upson B. Homocyst(e)inemia in daily practice: levels in coronary artery disease. Coron Artery Dis 1990; 1: 215–20
- Genest J J., MacNamara J R., Salem D N., Wilson P WF, Schaefer E J., Malinow M R. Plasma homocysteine in men with premature coronary artery disease. J Am Coll Cardiol 1991; 16: 1114–9
- Brattström L, Israelsson B, Jeppsson J O., Hultberg B. Folic acid–an innocuous means of reducing plasma homocysteine. Scand J Clin Lab Invest 1988; 48: 215–21
- Trell E. Community-based preventive medical department for individual risk factor assessment and intervention in an urban population. Prev Med 1983; 12: 397–402
- Refsum H, Ueland P M., Svardal A M. Fully automated fluorescence assay for determining total homocysteine in plasma. Clin Chem 1989; 35: 1921–27
- Hamfelt A. A simplified method for determination of pyridoxal phosphate in biological samples. Upsala J Med Sci 1986; 91: 105–9
- Andersson A, Brattström L, Israelsson B, Isaksson A, Hamfelt A, Hultberg B. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status. Eur J Clin Invest 1992; 22: 79–87
- Ueland P M., Brattström L, Refsum H. Atherosclerotic cardiovascular disease hemostasis, and endothelial function. The hemostatic system, endothelial function, and cardiovascular disease, R B. Franciss, jr. Marcell Dekker, Inc., New York 1992; 183–236
- Stampfer M J., Malinow M R., Willett W C., Newcomer L M., Upsow B, Ullmar D, Tishler P V., Hen-Nekens C H. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA 1992; 268: 877–81
- Reed T, Malinow M R., Christian J C., Upson B. Estimates of heritability of plasma homocyst(e)ine levels in aging adult male twins. Clin Genet 1991; 39: 425–8